Importance of the Quality of TME in Rectal Cancer Resection-A Systematic Review and Meta-Analysis
In brief
Good-quality rectal cancer surgery links to fewer recurrences and better survival
Across 15 studies involving 11,285 patients, about two-thirds had good-quality mesorectal excision. They had lower odds of local recurrence and higher odds of overall survival, including among patients who received preoperative treatment. The findings suggest preoperative therapy does not offset suboptimal surgery, but study heterogeneity and limited data on current treatments make the results hypothesis-generating, not definitive.
- Journal
- Cancer medicine (Q1)
- Published
- 1 November 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Carolin Kastner, Anne Hendricks, Johanna Wagner, Sophie Müller, Konstantin L Uttinger, Sven Flemming, et al.
- PMID
- 43056492
- DOI
- 10.1002/cam4.72384
Why clinicians should know about it
- Picked for Surgery (paper of the day, 21 November 2026): TME specimen quality relates to rectal cancer recurrence and survival
Abstract
Retrospective studies and analyses of RCTs showed that surgical quality of mesorectal excision affects oncological outcomes of rectal cancer patients. Objective of this study was to determine the impact of mesorectal excision quality on local recurrence and overall survival in rectal cancer patients. MEDLINE was searched till April 1, 2024, with MeSH terms: rectal cancer/neoplasm, total mesorectal excision, TME, rectal cancer surgery, macroscopic assessment/evaluation, quality/adequacy/completeness of surgery/mesorectum/resection specimen, prognosis, and outcome for randomized clinical trials, prospective and retrospective cohort studies reporting oncological outcomes and quality of the mesorectal excision. The main outcome and measures were local recurrence and overall survival. TME quality was classified into three grading categories (complete or mesorectal resection (MRR); nearly complete or intramesorectal resection (IMR); incomplete or muscularis propria resection (MPR)). Of 438 records screened and an additional three studies by cross-referencing, 15 articles with 11,285 individual patients were identified. Median age of included patients was 63, 55 (range 21, 0-95, 0). Pooled incidence of good (MRR), intermediate (IMR), and insufficient (MPR) TME quality was 65, 6%, 22, 8%, and 11, 6%, respectively. Insufficient TME quality was associated with locally advanced tumors. No difference in TME quality was observed between patients with and without neoadjuvant therapy. Pooled analysis showed lower odds for LR and higher odds for OS in patients with good TME quality, which is also shown in a subgroup analysis of neoadjuvantly treated patients. In conclusion, this meta-analysis confirms that good TME quality is associated with lower risk for local recurrence and higher probability for overall survival, an association that persisted also in neoadjuvantly treated patients. These findings suggest that neoadjuvant therapy will not compensate for suboptimal surgical quality; however, given the substantial heterogeneity across the included studies and the limited availability of data on contemporary treatment regimens, they should be regarded as hypothesis-generating rather than definitive.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.